Literature DB >> 26016996

Obesity-associated microRNA-26b regulates the proliferation of human preadipocytes via arrest of the G1/S transition.

Guangfeng Xu1, Chenbo Ji2, Guixian Song3, Chunmei Shi4, Yahui Shen2, Ling Chen4, Lei Yang4, Yaping Zhao1, Xirong Guo2.   

Abstract

MicroRNAs (miRNAs) are short, 20‑24 nucleotide non‑coding RNAs, which are involved in multiple biological processes, including obesity. Our previous investigation revealed that miRNA (miR)‑26b is differentially expressed in preadipocytes and mature adipocytes in humans. However, its role in the proliferation of human preadipocytes remains to be fully elucidated. In the present study, intracellular lipid accumulation was assessed using oil red O staining and the trigycerlide (TG) content was quantified using a TG assay kit, adipogenesis associated genes and cyclin D2 were analyzed using western blotting, and the effects of miR‑26b on the proliferation of preadipocytes was investigated using Cell Counting Kit‑8 assays and cell cycle analysis. Human preadipocytes overexpressing miR‑26b exhibited increased TG content in the adipocytes. During differentiation, the protein expression levels of adipogenesis‑associated marker genes, including peroxisome proliferator‑activated receptor γ, CCAAT/enhancer‑binding protein α, fatty acid‑binding protein and hormone‑sensitive lipase were upregulated in cells overexpressing miR‑26b, compared with the negative control cells. In addition, growth of human preadipocytes overexpressing miR‑26b occurred a slower rate and more remained in the G1 phase, compared with the negative control cells. In addition, miR‑26b downregulated the protein expression of cyclin D2. These results demonstrated that miR‑26b promoted differentiation and, at least party by targeting cyclin D2, attenuated cell proliferation via arresting the G1/S transition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26016996     DOI: 10.3892/mmr.2015.3858

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Impact of miR-26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non-canonical Wnt signalling.

Authors:  Duo Wang; Chang Liu; Yumei Wang; Wenjing Wang; Kang Wang; Xiujuan Wu; Zhigang Li; Cuimei Zhao; Li Li; Luying Peng
Journal:  Cell Prolif       Date:  2017-08-15       Impact factor: 6.831

2.  Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields.

Authors:  Yong Liu; Wen-Bin Liu; Kai-Jun Liu; Lin Ao; Jia Cao; Julia Li Zhong; Jin-Yi Liu
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 3.  MicroRNAs as Potential Regulators of Glutathione Peroxidases Expression and Their Role in Obesity and Related Pathologies.

Authors:  Petra Matoušková; Barbora Hanousková; Lenka Skálová
Journal:  Int J Mol Sci       Date:  2018-04-14       Impact factor: 5.923

4.  miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy.

Authors:  Enjiang Chen; Enliang Li; Hao Liu; Yue Zhou; Liang Wen; Jianxin Wang; Yi Wang; Longyun Ye; Tingbo Liang
Journal:  Int J Biol Sci       Date:  2021-02-08       Impact factor: 6.580

5.  Evaluation of circulating extracellular vesicles and miRNA in neutered and obese female dogs.

Authors:  Paola Caroline da Silva Nunes; Rosane Mazzarella; Juliano Coelho da Silveira; Deise Carla Almeida Leite Dellova
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

6.  Expression of microRNA‑26b and identification of its target gene EphA2 in pituitary tissues in Yanbian cattle.

Authors:  Bao Yuan; Wang-Yang Yu; Li-Sheng Dai; Yan Gao; Yu Ding; Xian-Feng Yu; Jian Chen; Jia-Bao Zhang
Journal:  Mol Med Rep       Date:  2015-08-06       Impact factor: 2.952

Review 7.  Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A Review.

Authors:  Francisco Javier Ruiz-Ojeda; Azahara Iris Rupérez; Carolina Gomez-Llorente; Angel Gil; Concepción María Aguilera
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.